Listed

Staar Surgical Co: Form 10-Q for the period ended Jul 3, 2020

Filed with the SEC on Aug 5, 2020 and accepted by EDGAR at Aug 5, 2020, 16:12 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-07-03. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-04 to 2020-07-03$4.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-04 to 2020-07-03$10.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-04-04 to 2020-07-03$10.8mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2020-01-04 to 2020-07-03$21.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-04-04 to 2020-07-03$24.4mus-gaap:GrossProfit
Gross profit6 months2020-01-04 to 2020-07-03$49.2mus-gaap:GrossProfit
Research and development3 months2020-04-04 to 2020-07-03$7.3mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-04 to 2020-07-03$14.2mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-04-04 to 2020-07-03$25.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-04 to 2020-07-03$51.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-04-04 to 2020-07-03−$1.1mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-04 to 2020-07-03−$2.2mus-gaap:OperatingIncomeLoss
Income tax3 months2020-04-04 to 2020-07-03$556.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-04 to 2020-07-03−$602.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-04-04 to 2020-07-03−$1.2mus-gaap:NetIncomeLoss
Net income6 months2020-01-04 to 2020-07-03−$1.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-04 to 2020-07-03−$0.03us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-01-04 to 2020-07-03−$0.03us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-04-04 to 2020-07-03−$0.03us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-01-04 to 2020-07-03−$0.03us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-04-04 to 2020-07-0345,354,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-01-04 to 2020-07-0345,152,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-01-04 to 2020-07-03−$8.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-04 to 2020-07-03$4.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-07-03$116.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-07-03$182.5mus-gaap:AssetsCurrent
Total assetsAt period end2020-07-03$218.0mus-gaap:Assets
Current liabilitiesAt period end2020-07-03$31.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-07-03$43.4mus-gaap:Liabilities
Shareholders' equityAt period end2020-07-03$174.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-20-036814. Last ingested by Listed: Nov 4, 2026, 17:00 ET. Listed shows no prices and gives no investment advice.